Sophia Vinogradov, MD
|School||UCSF School of Medicine|
|Address||4150 Clement Street|
San Francisco CA 94143
Sophia Vinogradov, M.D. is a Professor of Psychiatry in Residence; Interim Associate Chief of Staff for Mental Health, Associate Chief for Education and Research, Mental Health Service, at the San Francisco VA Medical Center; and Research Co-Director of the Prodrome Assessment, Research, and Treatment program at Langley Porter Psychiatric Institute, University of California, San Francisco. She received her M.D. from Wayne State University School of Medicine, obtained her psychiatry residency training at Stanford University School of Medicine, where she served as Chief Resident, and completed a Psychiatric Neurosciences Research Fellowship at the Palo Alto VA Medical Center and Stanford University.
psychopharmacologic treatment of serious mental disorders Psychopharmacologic treatment of serious mental disordersDiagnosis and treatment of psychotic disorders, Application of principles of cognitive and neuroscience to understanding of clinical disorders
Brain, Mind, and Behavior—integrated neuroscience/neurology/psychiatry course for medical students; fundamentals of cognitive neuroscience as applied to human psychopathology and clinical psychopharmacology
Dr. Vinogradov directs a translational clinical neuroscience laboratory that focuses on cognitive dysfunction in schizophrenia. In collaboration with basic neuroscientist, Michael Merzenich, Ph.D., she studies neuroscience-guided computerized cognitive training exercises for patients with schizophrenia that aim to drive enduring plastic changes in cortical processing. Dr. Vinogradov uses MEG and fMRI methods to probe the brain changes in both early sensory processing and higher-order cognitive operations in subjects who undergo this cognitive training. She is also examining changes in serum biomarkers (BDNF, D-serine) as a response to training. More recently, Dr. Vinogradov has begun to apply these methods to the study of adolescents who are prodromal for schizophrenia and young adults in early psychosis, with the goal of delaying or preventing the onset of a deteriorating psychiatric illness.
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share related concepts with this person.